$WYGC

Wenyuan Group Corp.

CIK:0000723533|SEC Filings

Condensed Consolidated Statements of Operations and Other Comprehensive (Loss) (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenues
Total revenues
Cost of revenues
Total cost of revenues
Gross profit
Operating expenses:
Professional expenses	18,000	18,000
Selling, general and administrative expenses	45,416	65,988
Total operating expenses	63,416	83,988
Loss from operations	(63,416)	(83,988)
Other income (expenses):
Other income (expenses), net	(258)	(1,972)
Total other income (expenses), net	(258)	(1,972)
Net loss	(63,674)	(85,960)
Other comprehensive income (loss)
Foreign currency translation gain (loss)	(324)	462
Comprehensive loss	$ (63,998)	$ (85,498)
Weighted average shares outstanding:
Weighted average shares outstanding: basic	82,610,375	80,884,279
Weighted average shares outstanding: diluted	82,610,375	80,884,279
Loss per share:
Loss per share: basic	$ (0.00)	$ (0.00)
Loss per share: diluted	$ (0.00)	$ (0.00)
Offline Product Sales [Member]
Revenues
Total revenues
Cost of revenues
Total cost of revenues
Offline Product Sales [Member] \| Related Party [Member]
Revenues
Total revenues

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (63,674)	$ (85,960)
Adjustment to reconcile net loss used in operating activities:
Depreciation and amortization	1,890	4,596
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(9,851)	25,754
Inventories		424
Accounts receivable from related parties	28,883
Accounts payable and accrued liabilities	40,809	14,844
Net cash used in operating activities	(1,943)	(40,342)
Cash flows from investing activities:
Acquisition of intangible assets	(641)
Net cash used in investing activities	(641)
Cash flows from financing activities:
Proceeds from a shareholder	7,168	22,413
Repayment to a shareholder	(4,595)	(9,080)
Net cash provided by financing activities	2,573	13,333
Effect of exchange rate changes in cash and cash equivalents	18	113
Net increase (decrease) in cash and cash equivalents	7	(26,896)
Cash and cash equivalents, beginning balance	144	27,208
Cash and cash equivalents, ending balance	151	312
Supplement Disclosures:
Interest paid
Income tax paid
Accrued capital expenditures	$ 722

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 151	$ 144
Accounts receivable, net of allowances from related parties		28,597
Inventories	6,332	6,246
Prepaid expenses and other current assets	20,802	10,767
Total current assets	27,285	45,754
Property and equipment, net	13,687	15,194
Intangible assets, net	1,449	1,609
Intangible assets under construction	12,384	10,867
Goodwill	1,132	1,132
TOTAL ASSETS	55,937	74,556
Current liabilities:
Accounts payable and accrued liabilities	120,954	78,088
Shareholder loan	10,977	8,465
Advances from customers	72	71
Total current liabilities	132,003	86,624
TOTAL LIABILITIES	132,003	86,624
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, $0.0001 par value, 50,000,000 authorized, nil shares issued and outstanding
Common stock, $0.0001 par value, 550,000,000 authorized, 82,610,375 and 82,610,375 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	8,262	8,262
Additional paid-in capital	21,842,920	21,842,920
Accumulated deficit	(21,928,508)	(21,864,834)
Accumulated other comprehensive income (loss)	1,260	1,584
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)	(76,066)	(12,068)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 55,937	$ 74,556